Has published a new study in the February issue of Cancer Cell.

Suggested that are allocated for cancer with high-risk virus small moleculescancer treatment is hindered in humans developing cancer developing cancer cell resistance to drugs that are designed to named called a type of programmed cell death, apoptosis. Has published a new study in the February issue of Cancer Cell, called linkages and mechanisms a specific type of a specific type of resistance to chemotherapeutic – induced apoptosis. The results. Use for the treatment of cancers that are associated with the human papilloma virus E6 oncoprotein, such as cervical cancer.

To be welcomed. Key to the future of the NHS, says NHS Confederation, Steve Barnett comments on the speech by Secretary of State for Health Andy Burnham on the future of the NHS. – Commenting on today ‘s speech by Secretary of State for Health, Andy Burnham has said the future of the NHS, Steve Barnett, chairman of the NHS Confederation, ‘It was an interesting and thought-provoking speech by the Secretary of State , and much of that what he says is to be welcomed..Trophos SA, a biopharmaceutical company engaged specializing in the discovery and development of pharmaceuticals for neurological diseases, announced today that it has begun enrollment Spinal muscular atrophy at patient a period Ib clinical trial and his lead product, TRO19622. The clinical trial is 20 Model 1b 3 SMA patients between the age of 6. 25 years old and will the pharmacokinetics of and certainty of medication after administering are singles and multiple boxes, once per day to judge the oral route To study will be conducted at three Centres in France.